Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Scholar Rock Holding Corporation

SRRKNASDAQ
Healthcare
Biotechnology
$47.70
$-0.30(-0.62%)
U.S. Market opens in 14h 26m

Scholar Rock Holding Corporation (SRRK) Stock Overview

Explore Scholar Rock Holding Corporation’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap4.8B
P/E Ratio-15.14
EPS (TTM)$-3.15
ROE-1.22%
Fundamental Analysis

AI Price Forecasts

1 Month$43.52
3 Months$36.80
1 Year Target$59.18

SRRK Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Scholar Rock Holding Corporation (SRRK) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 53.34, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $59.18.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -15.14 and a market capitalization of 4.8B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-2.06%
5-Day Change
1.27%
1-Month Change
6.14%
3-Month Change
16.91%
6-Month Change
32.46%
Year-to-Date (YTD) Change
9.84%
1-Year Change
26.51%
3-Year Change
433.60%
5-Year Change
-4.78%
All-Time (Max) Change
203.29%

Contact Information

857 259 3860
301 Binney Street, Cambridge, MA, 02142

Company Facts

1,280 Employees
IPO DateMay 25, 2018
CountryUS
Actively Trading

Frequently Asked Questions